Drug Use in Denmark for Drugs Having Pharmacogenomics (PGx) Based Dosing Guidelines from CPIC or DPWG for CYP2D6 and CYP2C19 Drug–Gene Pairs: Perspectives for Introducing PGx Test to Polypharmacy Patients

Background: The cytochrome P450 drug metabolizing enzymes CYP2D6 and CYP2C19 are the major targets for pharmacogenomics (PGx) testing and determining for drug response. Clinical dosing guidelines for specific drug-gene interactions (DGI) are publicly available through PharmGKB. The aim of this regis...

Descripción completa

Detalles Bibliográficos
Autores principales: Westergaard, Niels, Søgaard Nielsen, Regitze, Jørgensen, Steffen, Vermehren, Charlotte
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151550/
https://www.ncbi.nlm.nih.gov/pubmed/31963319
http://dx.doi.org/10.3390/jpm10010003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151550/
https://www.ncbi.nlm.nih.gov/pubmed/31963319
http://dx.doi.org/10.3390/jpm10010003

Ejemplares similares